Vitalhub Corp. (TSE:VHI) Receives Consensus Rating of “Buy” from Analysts

Vitalhub Corp. (TSE:VHI) has received an average recommendation of “Buy” from the seven research firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is C$13.00.

Separately, Canaccord Genuity Group set a C$15.00 price objective on shares of Vitalhub and gave the company a “buy” rating in a research report on Friday, August 28th.

Vitalhub Price Performance

Shares of TSE:VHI opened at C$7.25 on Friday. The firm’s 50 day simple moving average is C$7.67 and its 200 day simple moving average is C$7.43. Vitalhub has a fifty-two week low of C$6.46 and a fifty-two week high of C$11.80. The company has a market capitalization of C$459.21 million, a price-to-earnings ratio of 60.42, a P/E/G ratio of 1.18 and a beta of 1.40.

Vitalhub (TSE:VHI) last issued its earnings results on Thursday, August 6th. The company reported C$0.03 EPS for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The firm had revenue of C$31.74 million during the quarter. Equities research analysts expect that Vitalhub will post 0.2296467 earnings per share for the current year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.